Tower Research Capital (TRC)’s Arvinas ARVN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.5K Sell
2,351
-684
-23% -$6.38K ﹤0.01% 3576
2026
Q1
$32.2K Sell
3,035
-55
-2% -$681 ﹤0.01% 3122
2025
Q4
$36.6K Sell
3,090
-4,418
-59% -$48.2K ﹤0.01% 2665
2025
Q3
$64K Buy
7,508
+1,689
+29% +$12.8K ﹤0.01% 2329
2025
Q2
$42.8K Buy
5,819
+4,835
+491% +$35.6K ﹤0.01% 3101
2025
Q1
$6.91K Sell
984
-7,321
-88% -$115K ﹤0.01% 4000
2024
Q4
$159K Sell
8,305
-259
-3% -$6.29K ﹤0.01% 1859
2024
Q3
$211K Buy
8,564
+2,851
+50% +$74.4K 0.01% 1580
2024
Q2
$152K Buy
5,713
+4,846
+559% +$154K ﹤0.01% 2279
2024
Q1
$35.8K Sell
867
-5,858
-87% -$256K ﹤0.01% 2505
2023
Q4
$277K Buy
6,725
+3,267
+94% +$76.4K ﹤0.01% 1834
2023
Q3
$67.9K Sell
3,458
-6,023
-64% -$148K ﹤0.01% 2297
2023
Q2
$235K Buy
9,481
+4,175
+79% +$107K 0.01% 1437
2023
Q1
$145K Buy
5,306
+1,936
+57% +$61.2K ﹤0.01% 1555
2022
Q4
$115K Sell
3,370
-2,767
-45% -$116K ﹤0.01% 1724
2022
Q3
$273K Buy
6,137
+3,377
+122% +$164K ﹤0.01% 1636
2022
Q2
$117K Buy
2,760
+2,333
+546% +$117K ﹤0.01% 2162
2022
Q1
$29K Sell
427
-193
-31% -$13.2K ﹤0.01% 3171
2021
Q4
$51K Sell
620
-1,237
-67% -$101K ﹤0.01% 2741
2021
Q3
$153K Sell
1,857
-1,064
-36% -$94K ﹤0.01% 2051
2021
Q2
$225K Sell
2,921
-3,440
-54% -$239K 0.01% 1834
2021
Q1
$421K Buy
6,361
+5,164
+431% +$395K 0.01% 1380
2020
Q4
$102K Sell
1,197
-15,141
-93% -$522K ﹤0.01% 2325
2020
Q3
$386K Buy
16,338
+13,505
+477% +$391K ﹤0.01% 1964
2020
Q2
$95K Buy
+2,833
New +$120K ﹤0.01% 2499
2020
Q1
Sell
-223
Closed -$9K 3014
2019
Q4
$9K Sell
223
-1,971
-90% -$57.7K ﹤0.01% 2372
2019
Q3
$47K Buy
+2,194
New +$53.8K ﹤0.01% 1834
2019
Q2
Sell
-311
Closed -$5K 3642
2019
Q1
$5K Sell
311
-572
-65% -$10.1K ﹤0.01% 3037
2018
Q4
$11K Buy
+883
New +$14K ﹤0.01% 2369

Other funds holding ARVN

Tower Research Capital (TRC)'s ARVN Position: Q2 2026 in Review

Tower Research Capital (TRC) reduced its Arvinas (ARVN) stake by 23% in Q2 2026, selling an estimated $6.38K and leaving 2,351 shares worth $19.5K. The position accounts for ﹤0.01% of the portfolio, ranked #3576.

Tower Research Capital (TRC) first reported a position in ARVN in Q4 2018 and has held it in 29 quarters since. The position peaked at $421K in Q1 2021. 200 funds tracked by Wall St. Rank hold ARVN as of Q2 2026.

  • Tower Research Capital (TRC) held 2,351 shares of Arvinas worth $19.5K as of Q2 2026.
  • Tower Research Capital (TRC) sold 684 Arvinas shares in Q2 2026, an estimated $6.38K.
  • Arvinas made up ﹤0.01% of Tower Research Capital (TRC)'s portfolio in Q2 2026, its #3576 holding.
  • Tower Research Capital (TRC) first reported a position in Arvinas in Q4 2018 and has held it in 29 quarters since.
  • Tower Research Capital (TRC)'s Arvinas position peaked at $421K in Q1 2021.
  • 200 funds tracked by Wall St. Rank held Arvinas as of Q2 2026.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2026, filed 11 Aug 2026.